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Abstract: Background. Chlamydia trachomatis (CT) is the agent of the most common bacterial 
sexually transmitted infection worldwide, with a significant impact on women’s health. Despite the 
increasing number of studies about the vaginal microbiome in women with CT infections, 
information about the composition of the anal microbiome is still lacking. Here, we assessed the 
bacterial community profiles of vaginal and anal ecosystems associated or not with CT infection in 
a cohort of Caucasian young women. Methods. A total of 26 women, including 10 with a 
contemporary vaginal and ano-rectal CT infection, were enrolled. Composition of vaginal and anal 
microbiome was studied by 16S rRNA gene profiling. Co-occurrence networks of bacterial 
communities and metagenome metabolic functions were determined. Results. In case of CT 
infection, both vaginal and anal environments were characterized by a degree of dysbiosis. Indeed, 
the vaginal microbiome of CT-positive women were depleted in lactobacilli, with a significant 
increase in dysbiosis-associated bacteria (e.g., Sneathia, Parvimonas, Megasphaera), whereas the anal 
microbiota of CT-infected women was characterized by higher levels of Parvimonas and Pseudomonas 
and lower levels of Escherichia. Interestingly, the microbiome of anus and vagina had numerous 
bacterial taxa in common, reflecting a significant microbial ‘sharing’ between the two sites. In the 
vaginal environment, CT positively correlated with Ezakiella spp. while Gardnerella vaginalis co-
occurred with several dysbiosis-related microbes, regardless of CT vaginal infection. The vaginal 
microbiome of CT-positive females exhibited a higher involvement of chorismate and aromatic 
amino acid biosynthesis, as well as an increase in mixed acid fermentation. Conclusions. These data 
could be useful to set up new diagnostic/prognostic tools, offering new perspectives for the control 
of chlamydial infections. 
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1. Introduction 
Chlamydia trachomatis (CT) is the agent of the most common bacterial sexually 
transmitted infection (STI) worldwide, with a significant clinic, economic, and public 
health impact [1]. Urogenital CT infections in women (i.e., urethritis and cervicitis) are 
often asymptomatic and, when untreated, can lead to several sequelae and complications, 
including pelvic inflammatory disease, tubal infertility, and ectopic pregnancy [2]. 
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Moreover, urogenital infections are associated with an increased likelihood of HIV 
infection transmission and acquisition [3]. 
Besides the common urogenital localizations, Chlamydia can be found at extra-genital 
sites, such as pharyngeal and ano-rectal mucosa, on the basis of the sexual repertoires of 
the couples [4,5]. The prevalence of anal CT infections can be up to 5–15% in female 
populations that generally report unsafe intercourse and/or multiple sexual partners [6]. 
These infections are often asymptomatic or characterized by non-specific symptoms, 
acting as an important reservoir for further transmission [7,8]. 
The correlation between CT infection and composition of the cervico-vaginal 
microbiome has recently gained particular attention due to CT prevalence and clinical 
impact [9–11]. Some cross-sectional studies have demonstrated that bacterial vaginosis 
(BV) characterized by a dysbiosis status, with depletion of lactobacilli and increase in 
other anaerobic species, is an independent risk factor for STI acquisition, including genital 
CT infections [12,13]. Indeed, the vaginal environment of CT-positive women is often 
characterized by a decrease in Lactobacillus spp., together with a significant increase in BV-
associated bacterial taxa, such as Megasphaera spp., Atopobium vaginae, Gardnerella 
vaginalis, Dialister spp., and Prevotella spp. [14–16]. Nonetheless, many aspects of the 
vaginal microbiome during genital CT infection remain to be fully elucidated, and to the 
best of our knowledge, no information about the composition of the anal microbiome 
during ongoing CT infections in women is currently available. 
To fill this gap, we compared vaginal and anal microbiome composition in a cohort 
of 10 young women with contemporary vaginal/rectal CT infection and 16 CT-negative 
women. These data could be crucial to better understand the pathogenesis of genital and 
extra-genital CT infections, offering new perspectives for their prophylaxis and treatment. 
2. Results 
2.1. Study Population and Samples Analyzed 
A total of 26 women were enrolled in the study: 10 patients (38.5%) showed a 
contemporary genital and ano-rectal CT infection (i.e., CT-positive group), while the other 
16 (61.5%) were negative for CT at both anatomical sites (i.e., CT-negative group). Thus, 
10 coupled CT-positive vaginal (VS+) and anal samples (AS+), as well as 16 coupled CT-
negative vaginal (VS−) and anal samples (AS−) were analyzed. No significant differences 
were found in the mean age between the two groups (CT-positive: 22.8 ± 1.7, CT-negative: 
22.3 ± 2.8; p = 0.6). 
2.2. Diversity of Vaginal and Anal Microbiome 
The 16S rRNA gene profile of vaginal (VS, n = 26) and anal (AS, n = 26) samples 
encompassed a total of 1,028,693 quality-trimmed sequences, from 6412 to 54,485 reads 
per sample. The sequences were dereplicated into 1287 amplicon sequence variants 
(ASVs) matching a reference sequence in the Silva database and collapsed at the 7th level 
of taxonomic annotation (i.e., the species, if available) into 284 operational taxonomic units 
(OTUs). 
Richness and evenness, described by Chao1, Shannon, and Pielou indices (Figure S1), 
were higher in anal samples than in vaginal ones (p < 0.0001). The richness (Chao1 index) 
of both anal and vaginal microbiome was similar in CT-positive samples compared to CT-
negative ones (p > 0.05), while the evenness (Pielou index) was higher in VS+ than in VS− 
(p < 0.01). 
The beta-diversity among samples was assessed by weighted UniFrac metrics. In the 
plot of principal coordinate analysis (PCoA) reporting the two most informative 
dimensions (principal coordinate 1, PCo1; principal coordinate 2, PCo2), anal and vaginal 
samples clustered separately (PERMANOVA, p = 0.001), with anal samples grouping 
together at low values of PCo1 and PCo2 (p= 0.744, Figure 1a). Vaginal swabs were split 
into two groups (p = 0.023), with VS+ mostly defined by high PCo2 values and VS− by 
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high PCo1 ones. The ASVs that mainly contributed to positive PCo2, associated with VS+ 
metagenomes, belonged to Atopobium and Gardnerella vaginalis, while lactobacilli ascribed 
to the species Lactobacillus crispatus, Lactobacillus iners, and Lactobacillus gasseri were the 
main drivers of positive PCo1, associated with VS− samples (Figure 1b). Sequences 
assigned to the species Escherichia coli were frequent in AS samples and negatively 
contributed to both PCo1 and PCo2. 
 
Figure 1. β-diversity of the vaginal and anal microbiome. The microbial composition of vaginal (VS) 
and anal samples (AS) of CT-positive (+) and negative (−) women was analyzed. (a) Principal 
coordinates analysis (PCoA) plot based on weighted Unifrac distance. Each point corresponds to a 
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sample. (b) PCo1–PCo2 visualization of the contribution of each ASV. ASVs exerting the highest 
effect on PCo1 and/or PCo2 are labelled. 
2.3. Taxonomic Composition of Vaginal and Anal Bacterial Communities 
In vaginal samples, Firmicutes was the predominant phylum (60.8% and 83.2% in 
VS+ and VS−, respectively), followed by Actinobacteriota (23.8% and 6.4%), Bacteroidota 
(11.8% and 4.6%), and Proteobacteria (1.7% and 4.8%). Firmicutes were the most abundant 
also in anal samples (50.3% and 49.4% in AS+ and AS−, respectively), followed by 
Bacteroidota (24.7% and 25.4%), Proteobacteria (9.2% and 15.3%), and Actinobacteriota 
(6.0% and 4.4%) (Figure 2a). 
Lactobacillus was the sole genus shared by all the VS samples, ranging from 0.1 to 
99.5% (Figure 2b), with a mean relative abundance of 43.5% in VS+ and 69.3 in VS−. In 
several samples, Lactobacillus overwhelmed the other genera by more than one magnitude 
unit, with the sole exception of Gardnerella that accounted, on average, for 10.2% of the 
bacterial abundance. Prevotella was another abundant and recurrent taxon, occurring in 
24 vaginal samples with a mean abundance of 6.1%. Escherichia-Shigella, Atopobium, and 
Streptococcus exceeded the 2% of abundance but were more sporadically detected (9 out 
of 26 vaginal samples). Finegoldia, Peptoniphilus, Anaerococcus, and Candidatus Zinderia, 
although frequently detected (20 to 22 out of 26 samples), represented a minor component 
of the vaginal microbiota (<0.1%). Lactobacillus was scarce in two vaginal swabs (0.1 and 
2.5 % in VS−55 and VS+105, respectively), both dominated by Gardnerella vaginalis (46.6% 
and 25.6% in VS−55 and VS+105, respectively). Lactobacillus was especially low also in 
VS−24 (0.1%), where E. coli and Enterococcus faecalis outnumbered other taxa (40.1% and 
30.0%, respectively). 
A total of 32 ASVs ascribed to “Lactobacillus_uncultured” were further assigned by 
single BLAST alignment to the species L. crispatus, L. gasseri, L. fornicalis, L. coleohominis, L. 
acidophilus, L. iners, L. johnsonii, and L. reuteri, and the corresponding relative abundance 
was determined (Figure 2c). L. crispatus and L. iners were the most common and abundant 
species of lactobacilli in vaginal microbiota. L. crispatus was identified in 20 out of 26 
samples and represented 14.5% in VS+ and 24.9% in VS− of total bacteria. L. iners, detected 
in 14 VS, accounted for 22.7% in VS+ and 36.1% in VS−. L. reuteri and L. fornicalis, were 
observed in eight VS but represented a minor bacterial component: the former was < 0.2% 
in both groups and the latter was 2.6% in VS+ and 0.4% in VS−. L. gasseri was an occasional 
species detected only in four VS− samples, outnumbering all other bacteria in VS− 44 
(96.4%). None of the identified species of Lactobacillus showed significantly different 
abundance (p > 0.05) between CT-positive and negative vaginal samples.  
According to VALENCIA algorithm, the bacterial communities of the 26 VS were 
classified in seven community state types (CSTs), type III-A and III-B (five and six 
samples, respectively) being the most represented ones (Figure S2). These two CSTs were 
dominated by the genus Lactobacillus and, in particular, by L. gasseri. CST type IV-B 
encompassed six samples, generally CT-positive (five out six) and was characterized by a 
low relative abundance of lactobacilli. On the other side, in all the vaginal swabs ascribed 
to CST III-A, CT was never detected. 
The anal bacterial community was distributed among 205 genera, 23 of which at 
mean abundances greater than 1%. Prevotella was the dominant genus (14.7%), followed 
by Lactobacillus, accounting for 9.3% of total bacteria. Prevotella, Bacteroides, and 
Peptoniphilus were observed in all the AS. Dialister, Streptococcus, Escherichia-Shigella, 
Campylobacter, and Anaerococcus were absent in 1 or 2 samples out of 26. 




Figure 2. Taxonomic composition of the vaginal and anal microbiome. Stacked bar charts representation of microbiota 
composition (relative abundance) at phylum (a), genus (b), and Lactobacillus spp. (c) level. On the left, each vaginal and 
anal sample, stratified for CT positivity, is represented individually, whereas on the right the mean relative abundances 
for each group is depicted. Taxa present at relative abundances <0.5% are grouped in the “Other” category. 
Among the 284 different OTUs identified within the 52 anal and vaginal samples, 193 
(68%) were shared by the two sites (Figure S3). Among them, 127 OTUs were detected in 
vaginal and anal samples of the same subjects. Most of these OTUs were components of 
the female urogenital microbiota, such as Lactobacillus, Gardnerella, Streptococcus, 
Staphylococcus, Corynebacterium, and E. coli [17]. It is noteworthy that no significant 
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differences in the number of OTUs shared in VS and AS were found based on the presence 
or absence of CT. 
LEfSe algorithm was applied to reveal distinct features of the metagenomes 
characterized by the presence or absence of CT in vaginal samples. Overall, 23 taxa 
exhibited significantly different abundances (p < 0.05) between VS− and VS+ (Figure 3a, 
Figure S4). Four taxa were overabundant in VS−, including the order Lactobacillales and 
the genus Streptococcus anginosus. On the other side, 14 taxa characterized VS+ samples, 
including the genera Megasphera and Parvimonas and the species Metamycoplasma hominis, 
Sneathia amnii, and Mageibacillus indolicus. 
In anal metagenomes (Figure 3b, Figure S4), Enterococcus (E. faecalis and E. durans), 
Escherichia-Shigella, and Parasutterella were more abundant in AS−, while Desulfovibrio, 
Parvimonas, and Pseudomonas were more abundant in AS+. 
 
Figure 3. Distinctive taxonomic features characterizing CT-positive and negative samples. LDA 
score provided by LEfSe algorithm revealed the members of the microbial communities that were 
different between CT-positive and CT-negative groups, for vaginal (a) and anal (b) samples. 
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2.4. Taxonomic Co-Abundance Clusters 
To evaluate interspecies interactions, co-occurrence networks of bacterial 
communities were reconstructed in vaginal samples, irrespective of CT positivity. 
Correlations between CT, G. vaginalis, Lactobacillus spp., and the other bacterial taxa 
identified in vaginal samples were calculated using SCNIC and visualized with Cytoscape 
(Figure 4a). 
 
Figure 4. Taxonomic co-abundance clusters. Co-occurrence networks of bacterial communities of 
vaginal samples, irrespective of Chlamydia positivity. Significant correlations between G. vaginalis 
(a), Lactobacillus spp. (b) and the other bacterial taxa identified in vaginal samples were calculated 
using SCNIC and visualized with Cytoscape. Green and red bars represent positive and negative 
correlations, respectively. The thickness of the bar is proportional to the correlation coefficient r. 
CT co-occurred with Ezakiella. G. vaginalis network exhibited predominantly positive 
correlations, indicating cooperative relationships with vaginal bacterial taxa such as 
Parvimonas, Anaerococcus, Metamycoplasma hominis, Dialister, Atopobium, and Peptoniphilus. 
On the other hand, lactobacilli mainly showed negative correlations with other bacterial 
taxa (Figure 4b). For instance, Lactobacillus reuteri was negatively related to the presence 
of several BV-associated bacteria (e.g., Peptostreptoccocus, Peptoniphilus, Dialister, 
Anaerococcus), and L. crispatus to Fusobacterium. Some Lactobacillus species (i.e., L. gasseri. 
L. fornicalis, L. jensenii) were positively related to each other. 
  
Pathogens 2021, 10, 1347 8 of 16 
 
 
2.5. Predicted Metabolic Functions 
Metagenome reconstruction by 16S rRNA gene profiling of vaginal samples was 
exploited to predict the metabolic functions with PICRUSt2 and MetaCyc database. A total 
of 371 pathways were identified, 36 of which showed significantly different abundance (p 
< 0.05) between VS+ and VS− groups (Figure 5). 
The predicted pathways characterizing VS− were involved in central catabolism of 
lactose and galactose. Furthermore, modules of the biosynthetic pathways for 
peptidoglycan, geranyl-geranyl-diphosphate and mevalonate, coenzyme A, and CDP-
diacylglycerol were more represented in VS− samples. On the other side, the pentose 
phosphate shunt, the mixed acid fermentation, portions of the TCA cycle, glycogen, and 
starch degradation were enriched in VS+ samples. The pathways involved in amino acid 
biosynthesis also characterized VS+ metabolism, in particular the chorismate and super-
pathway for the biosynthesis of aromatic amino acids, glycine, serine, and alanine. 
Among the 363 pathways predicted by PICRUSt2 in anal samples, only 10 presented 
significant differences between AS+ and AS− groups (p < 0.05), all being more abundant 
in AS− samples (Figure S5). Differential abundance was observed mainly for degradation 
of aromatic compounds and amino acids (catechols and phenylpropanoids) and for 
pathways related to enterobacteria (sulfoglycolysis and enterobactin biosynthesis). 




Figure 5. Metabolic functional analysis prediction. The metabolic pathways reconstructed from 16S rRNA gene profile of 
vaginal samples using PICRUSt2 and presenting significant (p < 0.05) differential abundance between CT-positive and 
negative samples were reported. 




Composition of vaginal and anal microbiome in a cohort of sexually active young 
women was investigated comparing the bacterial composition of CT-infected women (n = 
10) to a negative control group (n = 16). 
Both vaginal and anal ecosystems were characterized by a degree of dysbiosis in case 
of CT infection, with several changes in the microbial composition compared to CT-
negative women. These modifications may occur as a result of CT infection or be a 
predisposing factor, favoring chlamydial survival and replication. 
In line with previous findings [18], the vaginal microbiome of CT-negative women 
was mainly constituted by Firmicutes, dominated at a lower taxonomic level by members 
of genus Lactobacillus. It is worth mentioning that, in some CT-negative subjects, even 
though asymptomatic, lactobacilli were diminished and replaced by BV-associated 
bacteria (e.g., Gardnerella) or intestinal-derived microorganisms (e.g., Escherichia, 
Enterococcus). Furthermore, several conditions of vaginal dysbiosis, such as BV or aerobic 
vaginitis, can be completely asymptomatic, even in presence of significant alterations of 
the microbial homeostasis [19,20]. As formerly reported [11,12], Lactobacillus showed a 
significant decrease in CT-positive women, with a contemporary increase in Sneathia, 
Parvimonas, Metamycoplasma, and Megasphaera. All these microorganisms have been 
associated with a BV status, strengthening the idea that the vaginal environment during 
chlamydial infections is often characterized by a dysbiotic condition [9]. The literature 
suggests that women with genital CT infection are most likely to be in CST IV, 
characterized by a reduction in Lactobacillus species [21]. Consistently, in our study cohort, 
a larger proportion of CT-positive women, as compared with the uninfected group, had a 
microbial profile similar to that of CST IV. 
When focusing on Lactobacillus genus, we found a high predominance of L. crispatus 
and L. iners species in both VS− and VS+ groups. L. crispatus has been recognized as a 
hallmark of vaginal health and eubiosis, while L. iners is considered to be a ‘transitional’ 
species, colonizing after perturbations of the vaginal environment [22]. Even though 
higher levels of L. iners have been previously associated with CT infection [12], in our 
cohort, this species did not show significantly different abundance between CT-positive 
and negative vaginal samples. Nevertheless, it has been recently shown that L. iners is the 
dominating taxon in a large subset of women worldwide, being its presence associated 
with unprotected sex practices and a higher number of sexual partners [23]. Moreover, 
among reproductive age women, younger women are more likely to have L. iners-
dominated vaginal communities than older women [24]. 
Anal samples were mainly characterized by the presence of Firmicutes, 
Proteobacteria and Bacteroidota, being Prevotella one of the most represented genus. This 
taxonomic composition is similar to previously described bacterial communities of the 
ano-rectal mucosa in subjects reporting unsafe anal intercourse [25,26]. Recent studies 
revealed that the microbiota in stools and anal swabs was similar and that differences 
between swab and stool samples within the same subject were significantly lower than 
those from samples between subjects [27,28]. Nevertheless, divergences in the relative 
abundance of taxa were reported, such as overrepresentation of Enterobacteriaceae and 
Bacillaceae in swabs and Clostridiales in stools. In accordance with these findings, AS 
metagenome showed a shift in composition compared to stool microbiota of a similar 
cohort of subjects, equivalent for age and geographical origin [29], revealing an increased 
amount of Proteobacteria and Actinobacteriota (mainly Gardnerella and Escherichia-
Shigella, respectively). The enrichment in members of the Prevotellaceae family has been 
previously associated with mechanical microtrauma and deposition of semen resulting in 
transient damages and inflammatory responses able to affect the commensal microbiota 
[25]. 
Interestingly, both in CT-positive and negative women, the microbiome of anus and 
vagina had numerous bacterial taxa (more than 60%) in common, reflecting a significant 
microbial ‘sharing’ between the two sites. It is well known that the ano-rectal region is a 
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significant reservoir of ‘health-promoting’ bacteria, Lactobacillus species in the rectum 
being possible contributors to the maintenance of a ‘normal’ vaginal microflora [30]. On 
the other hand, the ano-rectal region can be a source of potentially harmful microbes (e.g., 
Candida spp., Enterobacterales), able to easily reach and infect the vaginal mucosa [,31]. 
The significant ‘microbial translocation’ between the anal and vaginal sites is also pointed 
out by the important contribution of non-sexual inoculation of the ano-rectum with 
infected cervico-vaginal secretions in case of chlamydial infections [32]. Further studies, 
including culture-based techniques, will be needed to understand the exact magnitude of 
microbial translocation between anus and vagina both in presence and in absence of CT 
and to assess if these bacterial sharing can impact on CT infection and pathogenesis. 
Other interesting data emerged from the analysis of anal microbiome composition, 
stratified for CT positivity. Patients with anal CT infection were characterized by 
significantly higher levels of Parvimonas and Pseudomonas, whereas CT-negative women 
exhibited higher abundances of Escherichia and Enterococcus. In a previous paper focused 
on ‘men having sex with men’, we found similar microbial shifts in ano-rectal bacterial 
composition during sexually transmitted infections due to CT or N. gonorrhoeae. Indeed, 
infected patients were characterized by a depletion of Escherichia species, associated with 
an increase in anaerobic genera, including Peptoniphilus, Peptostreptococcus, and 
Parvimonas [26]. Even though the reasons behind these microbial changes are still 
unknown, we can make several hypotheses: (i) Chlamydia could elicit an inflammatory 
response (i.e., recruitment of natural killer cells and neutrophils with the production of 
cytokines and metalloproteinases) [33], able to alter the equilibrium of the bacterial 
communities of the anal microbiota, with the depletion of or increase in some species; (ii) 
the oxygen consumption by CT-infected cells or by the recruited leukocytes could favor 
the proliferation of strict anaerobes; (iii) Chlamydia can modify specific metabolic 
pathways for its nutritional requirement, leading to the preferential proliferation of 
selected microbial species in the anal microbiota.  
The depletion of Escherichia in the anal microbiota could precede the onset of CT 
infection, acting as a risk factor for pathogen replication on the ano-rectal site. If so, it 
would be possible to consider the administration of probiotic Escherichia strains as a new 
antibiotic-sparing approach to prevent chlamydial rectal infections. In this context, 
probiotic formulations of E. coli (e.g., Escherichia coli Nissle 1917) have been successfully 
employed for fighting several infectious agents, such as Salmonella, pathogenic E. coli, 
Shigella, Yersinia, Listeria, and Candida [34]. 
To identify patterns of co-expression in the vaginal microbiota, we established co-
abundant genera associations on the whole dataset. Irrespective of CT positivity, 
Lactobacillus was negatively correlated with several BV-associated genera (e.g., 
Peptostreptococcus, Peptoniphilus, Dialister), thus underlining their protective action against 
the overgrowth of dysbiosis-related microorganisms.  
On the other hand, Gardnerella occurred together with several dysbiosis-related taxa 
(e.g., Peptoniphilus, Dialister, Atopobium, Parvimonas, and Metamycoplasma hominis). These 
bacterial associations reflect the ability of bacteria to form highly structured polymicrobial 
biofilms on the vaginal epithelium during BV. Virulent strains of Gardnerella spp. initiate 
the formation of the biofilm and become a scaffolding, to which other BV-associated 
anaerobes, such as Atopobium vaginae, can thereafter attach [35]. Interestingly, CT was 
positively associated with Ezakiella spp., a recently described anaerobic Gram-positive 
species that can be found in human vagina [36]. 
Significant differences in several functional pathways were found between CT-
positive patients and the control group. Among all, a higher involvement of chorismate 
and aromatic amino acid biosynthesis, as well as an increase in mixed acid fermentation, 
were predicted at the vaginal level of CT-positive patients. Although non-predictive 
further studies are needed for a thorough comprehension of the dynamics taking place in 
the vaginal ecosystem, we can speculate that these variations reflect both the metabolic 
activities of dysbiosis-associated microbes found during chlamydial infections and the 
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activation of peculiar metabolic pathways employed by Chlamydia for its nutritional 
requirements. 
Intracellular growth and pathogenesis of Chlamydia species is controlled by the 
availability of the aromatic amino acid tryptophan [37]. In particular, CT is a tryptophan 
auxotroph and cannot synthesize tryptophan de novo, but only via indole salvage [38]. 
Therefore, increased biosynthesis of chorismate, a precursor of indole, indole derivatives, 
and tryptophan, could be attributed to the peculiar metabolic needs of Chlamydia. Instead, 
the increased involvement in mixed acid fermentation could reflect a dysbiotic 
lactobacilli-depleted vaginal ecosystem associated with CT infection. Indeed, BV status is 
characterized by the presence of many facultative and strict anaerobes, able to produce 
different volatile and non-volatile organic acids, also as a result of mixed acid sugar 
fermentation [39]. 
Future studies should address the vaginal and anal microbiomes composition in 
more women with and without CT. Studies with a larger cohort of subjects will be able to 
investigate other possible influences on these ecological niches, including but not limited 
to ethnicity as well as contraceptive and recent antibiotic use, which were strategically 
excluded from the current study to reduce variability between women. 
The outcome of this study could be useful to set up new diagnostic/prognostic tools, 
to find correlations with the presence of peculiar clinical or behavioral traits, and to 
evaluate the possibility of a different susceptibility to chlamydial STIs based on 
microbiome composition. Thus, intriguing perspectives on the control of chlamydial 
infections, in terms of prevention and treatment, could be investigated. For example, the 
study of vaginal and anal microbiome composition could help predict a higher risk of CT 
infection, implementing strategies for CT prevention in specific subgroups of women. 
Moreover, it could be possible to design the use of oral and/or vaginal probiotics (e.g., 
composed of lactobacilli) to prevent CT acquisition or to help clear the infection, along 
with antibiotic treatment. 
Further investigations with a prospective longitudinal study design would afford 
understanding whether these alterations precede the infection onset or if the pathogen 
itself perturbs the vaginal and anal environment. 
4. Materials and Methods 
4.1. Study Population and Sample Collection 
Eligible subjects were selected from a group of Caucasian non-pregnant young 
women attending the STI Outpatients Clinic of S. Orsola-Malpighi Hospital in Bologna 
(Italy) between May and December 2019 and reporting unsafe sexual intercourse. Criteria 
for the enrollment were as follows: (i) absence of ano-genital symptoms and (ii) presence 
of risk factors for CT infections (i.e., new, or multiple sexual partners, unprotected 
intercourse, history of a partner positive for STIs). 
Exclusion criteria included: being under the age of 18 years or over 26; having used 
antibiotic treatments in the month before the study; presence of inflammatory bowel 
diseases (IBD); presence of infectious intestinal pathologies; or use of enemas within 3 
days before sampling. Moreover, samples positive for Neisseria gonorrhoeae, Mycoplasma 
genitalium, HSV, and Treponema pallidum were excluded from the study. For each patient, 
personal and demographic data were recorded, and a clinical examination was carried 
out. Vaginal and an anal swab (E-Swab, Copan, Brescia, Italy) were collected from each 
woman for the detection of CT and the other STI pathogens and for the profiling of the 
microbiome. The adequacy of mucosal sampling in terms of cellularity degree was 
confirmed by means of PCR, targeting the human beta-globin gene [40]. 
The study protocol was reviewed and approved by the Ethical Committee of St. 
Orsola-Malpighi Hospital (7/2016/U/Tess). Written informed consent to the work was 
collected from all subjects. 
4.2. Diagnosis of Ano-Genital Infections 
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Vaginal and anal swabs were processed by Versant CT/GC DNA 1.0 Assay (Siemens 
Healthineers, Tarrytown, NY, USA), a duplex real-time PCR test assessing the presence of 
CT and N. gonorrhoeae DNA, as described in Marangoni et al. [41]. Each sample was tested 
for Mycoplasma genitalium with a quantitative PCR assay [42]. HSV and T. pallidum 
infections were excluded by means of a multiplex molecular approach (FTD genital ulcer, 
Fast Track Diagnostics, Esch sur Alzette, Luxembourg). 
Eligible subjects were allocated in one of the following groups: CT-negative 
(negativity for both vaginal and anal Chlamydia), and CT-positive (positivity both for 
vaginal and anal samples). 
4.3. Analysis of the Vaginal and Anal Microbiome 
Starting from the remaining DNA eluate of the Versant PCR plate, the V3–V4 
hypervariable regions of the bacterial 16S rRNA gene were amplified according to the 16S 
metagenomic sequencing library preparation protocol (Illumina, San Diego, CA, USA) 
and sequenced on a MiSeq platform (Illumina) in a single 2 × 300 bp paired-end run. 
Raw sequences were analyzed with the QIIME 2.0 pipeline, version 2020.11 [43]. The 
sequences were trimmed for primer removal with Cutadapt [44] and denoised with 
DADA2 to obtain ASVs [45]. Taxonomy assignment was carried out with the feature 
classifier VSEARCH [46], with SILVA SSU database release 138 (https://www.arb-
silva.de/download/arb-files/) as reference and the similarity threshold set at 0.97. ASVs 
identified as “Lactobacillus_uncultured” were further analyzed with a BLAST search into 
NCBI 16S ribosomal RNA sequences database to assign species level. The feature table 
was rarefied to the lowest number of reads (6412 per sample) to compute and compare, 
with the appropriate QIIME2 plugins, alpha- (Chao1, Shannon, and Pielou’s evenness) 
and beta-diversity (Weighted UniFrac) (i.e., Kruskal–Wallis test and PERMANOVA for 
alpha- and beta diversity, respectively). Differences were considered significant for p < 
0.05. PCoA was computed with QIIME2, based on the beta-diversity distance matrix. 
The taxonomic profiles of vaginal microbial communities were analyzed by 
VALENCIA, a nearest centroid-based tool that classifies samples according to the 
similarity to a set of 13 reference CSTs [24].  
Linear discriminant analysis effect size (LEfSe, 
http://huttenhower.sph.harvard.edu/galaxy) algorithm was utilized to discover 
distinctive taxonomic features characterizing CT-positive and negative samples [47]. Taxa 
presenting a significant differential abundance (p < 0.05) and logarithmic LDA (linear 
discriminant analysis) score > 2 were considered microbial biomarkers of CT-positive or -
negative samples. 
Correlations between Lactobacillus spp., G. vaginalis, CT, and other bacterial taxa 
identified in vaginal samples were determined using sparse co-occurrence network 
investigation for compositional data (SCNIC) (https://github.com/shafferm/SCNIC) by 
computing Spearman correlation coefficients (p < 0.05) [48]. 
The vaginal dataset was analyzed with PICRUSt2 to predict metagenome functions 
and investigate significant differences between CT-positive and -negative samples in 
terms of metabolic pathways [49]. The tool predicted the enzymes and the relative 
MetaCyc pathways abundances [50]. STAMP was used to visualize the results and 
perform statistical analysis [51]. 
Supplementary Materials: The following are available online at 
www.mdpi.com/article/10.3390/pathogens10101347/s1, Figure S1: Alpha diversity metrics of anal 
and vaginal microbiome, Figure S2: Classification of vaginal microbial communities in VALENCIA 
community state types, Figure S3: Microbial sharing among vaginal and anal microbiota, Figure S4: 
Taxonomic biomarkers characterizing CT-positive and negative samples. Figure S5: Metabolic 
functional analysis prediction of anal samples. 
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